Skip to main content

Table 1 Patient characteristics of controls, POA/OPOI and DOR patients

From: Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women?

 

POA/OPOI

DOR

Controls

P value (Sidak test)

N

135

155

32

 

Age (years)

34.5 ± 3.21,2

43.2 ± 2.41,3

33.1 ± 3.72,3

10.001, 20.04, 30.001

BMI (kg/m2)

24.0 ± 4.8

24.3 ± 5.0

22.0 ± 5.5

 

FSH (mIU/mL)

13.4 ± 14.24,5

17.8 ± 13.14,6

6.3 ± 2.55,6

40.02, 50.02, 60.001

AMH (ng/mL)

0.9 ± 1.17,8

0.3 ± 0.37,9

3.3 ± 2.18,9

70.001, 80.001, 90.001

Race n (%)

    

Caucasian

90 (66.7)

119 (76.8)

19 (59.4)

 

African

16 (11.9)

18 (11.6)

4 (12.5)

 

Asian

29 (21.5)

18 (11.6)

9 (28.1)

 
  1. Values are presented as means ± SD.